Automatic Oxygen Titration in Patients After SARS-CoV-2 Infection
Post-COVID19
About this trial
This is an interventional treatment trial for Post-COVID19 focused on measuring post SARS-CoV-2 infection, long-term oxygen therapy, automatic oxygen-titration, hypoxemia
Eligibility Criteria
Inclusion Criteria:
- validated COVID19 disease in case history
- hypoxemia (PO2 < 55 mmHg) under room air conditions (rest or during exercise) or SpO2 <88% during exercise
- already established Long-term oxygen therapy or given indication for a Long-term oxygen therapy
Exclusion Criteria:
- acute infection
- cardiovascular diseases that limit physical fitness
- orthopedic diseases preventing the patient from undergoing the walking tests
Sites / Locations
- Klinikum Berchtesgadener Land, Schön Kliniken
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Experimental
ESWT Order A and B
ESWT Order B and A
Stairs Order A and B
Stairs Order B and A
First Endurance Shuttle Walk Test using the automatic oxygen titration (O2matic) with the target range being 90 - 94% SpO2, the second Endurance Shuttle Walk Test using the prescribed constant flow oxygen therapy.
First Endurance Shuttle Walk Test using the prescribed constant flow oxygen therapy, the second Endurance Shuttle Walk Test using the automatic oxygen titration (O2matic) with the target range being 90 - 94% SpO2.
First Stair Walking Test using the automatic oxygen titration (O2matic) with the target range being 90 - 94% SpO2, the second Stair Walking Test using the prescribed constant flow oxygen therapy.
First Stair Walking Test using the prescribed constant flow oxygen therapy, the second Stair Test using the automatic oxygen titration (O2matic) with the target range being 90 - 94% SpO2.